A synthetic peptide for use as a blocking control in assays to test for specificity of FLCN antibody, Alternative Names: FLCN control peptide, FLCN antibody Blocking Peptide, Anti-FLCN Blocking Peptide, folliculin Blocking Peptide, BHD Blocking Peptide, DKFZp547A118 Blocking Peptide, FLCL Blocking Peptide, FLJ45004 Blocking Peptide, FLJ99377 Blocking Peptide, MGC17998 Blocking Peptide, MGC23445 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
FLCN
(Folliculin (FLCN))
Substanzklasse
Amino Acid
Hintergrund
This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax.